Brad Somer

1.1k total citations
4 papers, 99 citations indexed

About

Brad Somer is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Brad Somer has authored 4 papers receiving a total of 99 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Pulmonary and Respiratory Medicine, 2 papers in Oncology and 1 paper in Molecular Biology. Recurrent topics in Brad Somer's work include Vascular Tumors and Angiosarcomas (1 paper), Cancer Genomics and Diagnostics (1 paper) and Radiopharmaceutical Chemistry and Applications (1 paper). Brad Somer is often cited by papers focused on Vascular Tumors and Angiosarcomas (1 paper), Cancer Genomics and Diagnostics (1 paper) and Radiopharmaceutical Chemistry and Applications (1 paper). Brad Somer collaborates with scholars based in United States. Brad Somer's co-authors include Peter Sportelli, Thomas E. Hutson, Wolfram E. Samlowski, Paul Richards, Nicholas J. Vogelzang, Robert A. Figlin, John F. Palma, James A. Reeves, Herbert I. Hurwitz and Heinz‐Josef Lenz and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and The Journal of Urology.

In The Last Decade

Brad Somer

4 papers receiving 99 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brad Somer United States 4 49 47 38 18 18 4 99
Nuria Mulet Spain 5 85 1.7× 46 1.0× 36 0.9× 12 0.7× 25 1.4× 11 120
Lucas Wong United States 4 75 1.5× 64 1.4× 28 0.7× 14 0.8× 6 0.3× 6 129
Helmut Lambertz Germany 4 81 1.7× 23 0.5× 28 0.7× 21 1.2× 8 0.4× 4 99
Nieves Martínez Lago Spain 8 121 2.5× 40 0.9× 51 1.3× 29 1.6× 33 1.8× 44 165
Arnaldo Marín Chile 5 61 1.2× 52 1.1× 48 1.3× 10 0.6× 19 1.1× 12 136
Zhigang Han China 4 48 1.0× 47 1.0× 56 1.5× 11 0.6× 32 1.8× 5 95
David Sommerhalder United States 7 66 1.3× 89 1.9× 47 1.2× 10 0.6× 12 0.7× 43 162
Reetta Peltonen Finland 6 81 1.7× 38 0.8× 20 0.5× 22 1.2× 39 2.2× 8 133
J.-F. Emile France 4 77 1.6× 63 1.3× 61 1.6× 4 0.2× 24 1.3× 5 133
Edward Y. Zhu United States 5 28 0.6× 16 0.3× 26 0.7× 9 0.5× 24 1.3× 13 73

Countries citing papers authored by Brad Somer

Since Specialization
Citations

This map shows the geographic impact of Brad Somer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brad Somer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brad Somer more than expected).

Fields of papers citing papers by Brad Somer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brad Somer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brad Somer. The network helps show where Brad Somer may publish in the future.

Co-authorship network of co-authors of Brad Somer

This figure shows the co-authorship network connecting the top 25 collaborators of Brad Somer. A scholar is included among the top collaborators of Brad Somer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brad Somer. Brad Somer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
1.
Hurwitz, Herbert I., Benjamin Tan, James A. Reeves, et al.. (2018). Phase II Randomized Trial of Sequential or Concurrent FOLFOXIRI-Bevacizumab Versus FOLFOX-Bevacizumab for Metastatic Colorectal Cancer (STEAM). The Oncologist. 24(7). 921–932. 48 indexed citations
2.
3.
Cho, Daniel C., Thomas E. Hutson, Wolfram E. Samlowski, et al.. (2012). Two phase 2 trials of the novel Akt inhibitor perifosine in patients with advanced renal cell carcinoma after progression on vascular endothelial growth factor‐targeted therapy. Cancer. 118(24). 6055–6062. 36 indexed citations
4.
Vogelzang, Nicholas J., Thomas E. Hutson, Wolfram E. Samlowski, et al.. (2009). Phase II study of perifosine in metastatic renal cell carcinoma (RCC) progressing after prior therapy (Rx) with a VEGF receptor inhibitor. Journal of Clinical Oncology. 27(15_suppl). 5034–5034. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nuria Mulet Breakdown of academic impact, for papers by Lucas Wong Breakdown of academic impact, for papers by Helmut Lambertz Breakdown of academic impact, for papers by Nieves Martínez Lago Breakdown of academic impact, for papers by Arnaldo Marín Breakdown of academic impact, for papers by Zhigang Han Breakdown of academic impact, for papers by David Sommerhalder Breakdown of academic impact, for papers by Reetta Peltonen Breakdown of academic impact, for papers by J.-F. Emile Breakdown of academic impact, for papers by Edward Y. Zhu
Rankless by CCL
2026